Further six Minilabs for Ethiopia
Shortly, six more GPHF-Minilabs will go to Ethiopia in East Africa. They will complement the work of the national medicines control authority and are donated by the “Promoting the Quality of Medicines” programme run jointly by USP (United States Pharmacopeial Convention) and USAID. After their arrival, the Minilabs will be disseminated to several regional drug control offices and thus help in reducing the workload on the central level. Since ten years, USP and GPHF are partnering in their fight against counterfeit medicines. For example, last year, GPHF Project Manager Dr. Jähnke supported the ongoing efforts and run an extra Minilab training course in the country. Globally, in the past ten years, the USP/USAID “Promoting the Quality of Medicines” programme donated 180 Minilabs already.
Friederike Segeberg new chairperson of the GPHF
At the annual meeting of the Global Pharma Health Fund (GPHF) Friederike Segeberg was elected as the new chairperson of the charitable organization. She succeeds Frank Gotthardt, who now serve as Vice Chairman besides Dr. Walter Huber. The board of the GPHF is completed by Treasurer Stefan D. Schröder.
GPHF-Minilab™ identifies fake malaria pills in Malawi
Due to the GPHF-Minilab™ counterfeit antimalarial medicines were identified in Malawi. Sold by illegal street vendors the falsified products contained none of the declared active pharmaceutical ingredient. These counterfeit medicines represent a serious health risk to the Malawian population. For more information please see here.
GPHF-Minilabs for Tanzania
For the advancement of pharmaceutical services in Tanzania, the German association of researched-based pharmaceutical manufacturers announced a trio partnership among some of their member companies, the public German International Cooperation and the faith-based development sector in Berlin this week. The Minilab developed by the Global Pharma Health Fund (GPHF) will play an essential part of the vocational capacity building project for pharmaceutical technicians. It will help in assuring access to quality medicines even in rural Tanzania and protect consumers against the use of poor-quality and falsified medicines. The dispatch of four Minilabs is combined with an appropriate training at the Muhimbili University of Health and Allied Sciences in Tanzania’s capital Dar es Salaam.
Minilab training in Burundi
Onset February this year, more than ten people have been trained in the use of the Minilab at the LifeNet health care centre of Bujumbura (Burundi). The training was run by Nyaah Ngoh Fidelis, a pharmacist from the health service of the Presbyterian Church in Cameroon. The Minilab was donated by the German Institute for Medical Mission, a faith-based organisation run by Protestant doctors in Tübingen. For more information please see here.
Minilab Method Extension: Five more test protocols supplied
The Minilab’s method inventory has now been extended to overall 75 drug compounds. New and old Minilab users will clearly benefit from this performance improvement, for example the identification and content verification of more essential cardiovascular medicines. Appropriate reference standards are supplied. Beyond this, the Minilab’s technical platform stays unchanged and can fully manage the new five arrivals atenolol, bisoprolol, captopril, hydrochlorothiazide and clomifene. The new supplements are available in English, French and Spanish. For more information please see here.
E-learning course on fake medicines
The Institute of Research Against Counterfeit Medicines (IRACM) is now offering an e-learning programme on fake medicines helping consumers to understand the difference between falsified, counterfeit and substandard medicines permanently floating the global markets in disturbing quantities. With every passing day, men, women and children, even yourself and family members can become a victim of counterfeit medicines. Increase your knowledge, get protected and start the training now at www.iracm.com/elearnlanding/en.
GPHF donates minilabs to Madagascar
To prevent people from counterfeit drugs the GPHF once again donated two of his minilabs, this time to Madagascar. The picture shows GPHF Chairman Frank Gotthardt (right) during the handing-over of the minilabs to the Malagasy Prime Minister Roger Kolo (centre) being also the Minister of Health in the country. For more information please see here.
Minilab course in Ethiopia
In Ethiopia, last week, fourteen more pharmacists have been trained in the use of the GPHF-MinilabTM. The course, done by the GPHF project manager Dr. Richard Jähnke, took place at the School of Pharmacy being part of the College of Health Sciences of Addis Ababa University (AAU). For more information please see here.
One Year Anniversary of “Fight the Fakes” – Interpol warns about fake drugs
Today marks the one year anniversary of the Fight the Fakes campaign, initiated by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). In the meantime the global awareness campaign against counterfeit drugs is supported by more than twenty international organisations including the GPHF. Under the motto “Speak about fake medicines” numerous activities have been carried out. For more information please visit www.fightthefakes.org
How important the struggle against the counterfeiting of medicines still is, has been recently demonstrated during an international meeting of Interpol in Dublin. It is reported that millions of people worldwide are affected by counterfeit drugs that threaten the healthcare systems of whole countries. In many cases the counterfeiting of drugs has become a part of the organized crime.
Fake medicines galore found in a Bangladesh factory
The medicines market is flooded with a large number of spurious medical products in Bangladesh while traders take stock of ineffective regulation and lack of market monitoring. A well prepared police investigation lead to a joint drive by the health district administration and the Rapid Action Battalion (RAB) at a counterfeit drug factory in the Chittagong district end of last month recovering plenty of falsified medicines including their starting material to treat infections and other disorders.
Fake Medicines and Malaria
One third of the antimalarials in Africa are counterfeit and it has been estimated that fake antimalarial medicines contribute to nearly 450,000 preventable deaths per year. The international campaign Fight The Fakes, also supported by the GPHF, now published this descriptive infographic on these topics.
Minilabs will support drug quality verification study in Malawi
The Global Pharma Health Fund (GPHF) contributes one of its Minilabs to a drug quality verification study in Malawi. Under the mentorship of Professor Lutz Heide from the University Tübingen, the study is designed to monitor the quality of antimalarial and antibacterial medicines circulating in the country and will be performed by the pharmaceutical institute of the University of Malawi based in Blantyre. Collaborators are Albert Petersen form the German Institute for Medical Mission and Dr. Richard Jähnke from the GPHF. A second GPHF-Minilab for this project will be donated by the University of Tübingen and a third one is already sitting at the Nkhoma Synod Health Department of the Central Africa Presbyterian Church.
Obstacles to fight counterfeit medicines effectively
Using the GPHF-MinilabTM, a large quantity of counterfeit medicines were detected at the Luanda docks in Angola in June 2012. The tablets for the treatment of malaria and worm infections contained no or wrong active ingredients and over a million treatment packs of them were hidden in loudspeakers arriving in sea containers from China. How this case developed since then and what conclusion should be drawn from this case for the future is now discussed by an international team of experts including Dr. Richard Jähnke from the Global Pharma Health Fund (GPHF) in the September issue of The Lancet. See the full correspondence to the editor at “Falsified medicines in Africa: all talk, no action”.
Minister joins Minilab training
Onset 2014, the Global Pharma Health Fund (GPHF) and the Promoting the Quality of Medicines (PQM) programme run by USP/USAID each provided one Minilab to the National Drug Quality Laboratory in Guinea-Conakry. Last month a Minilab introductory training for more than twenty people was performed. Even the Minister of Health, Médecin Colonel Dr. Remy Lamah, paid a visit to the lab. He highly spoke about the technical assistance given in fighting the menace of fake and substandard quality medicines known to circulate in the West African region. The training on the GPHF-Minilab was covered by the local TV station too.
Expanding antimalarial medicines quality monitoring in Kenya
In Kenya last week, six more counties have been equipped with Minilabs and twenty two more technicians been trained at the National Quality Control Laboratory and Pharmacy & Poisons Board in Nairobi by the ongoing antimalarial quality surveillance project run by the Promoting the Quality of Medicines programme (PQM) maintained jointly by USP and USAID. The technical briefing on the Minilab’s operational procedures was supported by the Global Pharma Health Fund. For more information please see here.
Training on the GPHF-Minilab™ in India
Onset this month, five people including three doctors, one pharmacist and a senior manager have been trained on the use of the GPHF-MinilabTM at the Baptist Christian Hospital (BCH) in Tezpur, an Indian town in the Assam state near the Nepalese border. The training was conducted by the staff from the Community Development Medicinal Unit (CDMU) based in Odisha-Bhubanewar and the feedback on the training was excellent. Uncontrolled cross-border trading is immanent in the Tezpur region and the chance to see even falsified medicines is high. BCH Tezpur and CDMU Odisha are part of the Ecumenical Pharmaceutical Network using Minilabs developed by the Global Pharma Health Fund (GPHF) and donated by the German Institute for Medical Mission. Photo credit: BCH Tezpur.
Tons of fake medicines have been secured
During an international operation coordinated by INTERPOL more than 200 tons of fake and illicit medicines have been secured in West Africa. The market value of the confiscated goods was about 25 million US dollar. For more information go to http://www.interpol.int/News-and-media/News/2014/N2014-099
Once again the GPHF-Minilab™ has proved a reliable assistant to the local drug inspectors. Thanks to the mobile laboratory a fake antibacterial without the prescribed ingredient was detected in Cameroon.
Eleven new partners join global Fight the Fakes campaign
Following the campaign’s six-month anniversary, Fight the Fakes announces eleven new partners, bringing the total number of member organizations to twenty-five. New partners, representing wholesalers, pharmacists, mobile app services, coalitions for consumer protection and generic pharmaceutical manufactures, join the campaign to speak up and spread the word about the devastating impact of fake medicines. These organizations add to a diverse group of standing partners, including healthcare professionals, disease-specific organizations, research-institutes, product-development partnerships, foundations, non-profits and the private sector, coordinating efforts in the fight against fake medicines.
The eleven new partners are the Alliance for Safe Online Pharmacies (ASOP), the Alliance for Safe Online Pharmacy in the EU (ASOP EU), the Center for Safe Internet Pharmacies (CSIP), the European Association of Pharmaceutical Wholesalers (GIRP), the Generic Pharmaceutical Association (GPhA), the International Federation of Pharmaceutical Wholesalers (IFPW), the International Pharmaceutical Students Federation (IPSF), Mobilium, the Partnership for Safe Medicines (PSM), PSM India and the Pharmaceutical Security Institute (PSI).
For more information please visit the website www.fightthefakes.org
GPHF run Minilab training in Nigeria
From April 27 till May 02, 2014 the Global Pharma Health Fund (GPHF) run a training course on the GPHF-Minilab in Lagos, Nigeria. Headed by Dr. Richard Jähnke, 25 pharmacists from Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) as well as Central Medical Stores were trained in the use of the mobile miniature lab to detect counterfeit drugs.
Counterfeit and substandard drugs are a serious health problem in Nigeria, too. A national drug quality survey performed in 2001 showed that 40% of all medicines were counterfeit and since 2009, NAFDAC destroyed counterfeit medicines and other substandard regulated products worth € 900 million. More than 50 Minilabs are already located in Nigeria and represent a major contribution to protect the Nigerian people from the danger of counterfeit drugs that may constitute a serious health risk.
The meaning of the training was to optimize the use of the Minilab in Nigerians ports and hospitals and to demonstrate the versatile applications of the Minilab test methods. Dr. Jähnke was more than happy with the outcome of the training and pointed out the engagement of all the participants. They were also highly satisfied, too, and described the training course as a “superb experience” and the Minilab’s operation procedures itself as easy and stress-free to perform.
GPHF-Minilab joins Festival of Sciences in the USA
The Global Pharma Health Fund (GPHF) partnered with the U.S. Department of State on the theme to "Find the Fake!" by hosting an exhibit based on the Minilab kit at the USA Science and Engineering Festival on April 25-27 in Washington, DC. The Festival inspires the next generation of scientists and engineers by celebrating science and innovation. The 2014 Festival was attended by over 325,000 students.
The exhibit featured a hands-on experiment from the Minilab kit to highlight the ease of counterfeiting and the importance of drug testing. The presence at the Festival helped build awareness about the need to improve medicines quality and combat the proliferation of counterfeit medicines in the developing world.
CePAT receives first Minilab to aid in detection of fake medicines
The Center for Pharmaceutical Advancement and Training (CePAT) in Ghana has just received a GPHF-Minilab™ to aid in detection fake medicines. Minilab checks medicines for the correct active pharmaceutical ingredients (API) and equips regulatory authorities with a portable and low-cost means of protecting patients from counterfeit drugs.
CePAT and Global Pharma Health Fund (GPHF) last year formed a strategic alliance to work together to improve access to good quality, safe, and beneficial medicines and also strengthen human resource capacity to conduct quality control testing to detect substandard and counterfeit medications in Africa.
General Meeting of GPHF with good results
On the occasion of its Annual General Meeting, the Global Pharma Health Fund (GPHF) issued a positive statement on the past year's project work. A total of 76 GPHF-Minilabs were delivered and seven more tests for active pharmaceutical ingredients were developed. Overall more than 650 mobile laboratories to detect counterfeit drugs are now working in nearly 90 countries worldwide. With the minilab overall 70 drug compounds including their appropriate fixed-dose combination products can be identified. During the meeting Frank Gotthardt (Chairman), Dr. Walter Huber (Vice Chaiman) and Stefan D. Schröder (Treasurer) were re-elected for three more years.
GPHF joins as partner of „Fight the Fakes“
The Global Pharma Health Fund (GPHF) has become partner of the global campaign “Fight the Fakes”. The campaign’s objective is to raise awareness on the growing issue of counterfeit drugs and the related health risks. “Fight the Fakes” is run by various international healthcare organizations. For more information on “Fight the Fakes” and the engagement of the GPHF please visit http://fightthefakes.org.
GPHF-Minilab Method Extension 2014
The GPHF-Minilab is now capable of verifying drug identity and content on 70 active pharmaceutical ingredients for a plethora of vital medicines including their most common fixed-dose combinations. The new test protocols are concerned about injectable antibiotics for new-born sepsis and TB (cefazolin, ceftriaxone, amikacin, capreomycin and streptomycin). The new method inventory also includes modified released granules for para-amino salicylate (PAS) sodium and metformin tablets combined or not combined with glibenclamide thus closing the gap on essential antidiabetics. For more information please see: